Vicente E Torres

发表

Automated Segmentation of Kidneys from MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease.

Jianbing Zhu, Youngwoo Kim, D. Landsittel, 2016, Clinical journal of the American Society of Nephrology : CJASN.

Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes.

A. Chapman, V. Torres, J. Grantham, 2005, Clinical journal of the American Society of Nephrology : CJASN.

Tolvaptan in patients with autosomal dominant polycystic kidney disease.

Eiji Higashihara, R. Gansevoort, A. Chapman, 2012, The New England journal of medicine.

Volume progression in polycystic kidney disease.

Bernard F King, K. Bae, S. Klahr, 2006, The New England journal of medicine.

Therapeutic Area Data Standards for Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC).

Jon Neville, Eslie Dennis, Bron Kisler, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Quantitative assessment of hepatic fibrosis in an animal model with magnetic resonance elastography

Armando Manduca, Richard L Ehman, Meng Yin, 2007, Magnetic resonance in medicine.

Blood pressure in early autosomal dominant polycystic kidney disease.

Kaleab Z. Abebe, Charity G Moore, K. Bae, 2014, The New England journal of medicine.

Autosomal dominant polycystic kidney disease

Yves Pirson, V. Torres, P. Harris, 1992, The Lancet.

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist

Vincent H Gattone, V. Torres, P. Harris, 2003, Nature Medicine.

Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.

Douglas Landsittel, Kyongtae Ty Bae, Diego R. Martín, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials.

Bradley J Erickson, Laureano J Rangel, Eric J Bergstralh, 2015, Journal of the American Society of Nephrology : JASN.

Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.

Paul A Thompson, Bernard F King, Marijn E Brummer, 2005, Clinical journal of the American Society of Nephrology : CJASN.

Automatic total kidney volume measurement on follow-up magnetic resonance images to facilitate monitoring of autosomal dominant polycystic kidney disease progression.

Bradley J Erickson, Panagiotis Korfiatis, Joshua D. Warner, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Autosomal dominant polycystic kidney disease: the last 3 years.

V. Torres, P. Harris, Peter C Harris, 2009, Kidney international.

B9D1 is revealed as a novel Meckel syndrome (MKS) gene by targeted exon-enriched next-generation sequencing and deletion analysis.

V. Torres, P. Harris, K. Hopp, 2011, Human molecular genetics.

Quantitative MRI of kidneys in renal disease

Bradley J Erickson, Panagiotis Korfiatis, Sudhakar K Venkatesh, 2018, Abdominal Radiology.

Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases

V. Torres, P. Harris, Peter C Harris, 2006, Nature Clinical Practice Nephrology.

The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease.

Gregory R Pond, Klaus Zerres, G. Pond, 2002, Journal of the American Society of Nephrology : JASN.

Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease.

James Glockner, Eric J Bergstralh, Bernard F King, 2010, Journal of the American Society of Nephrology : JASN.

Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study.

Eiji Higashihara, K. Bae, R. Gansevoort, 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.

Paul A Thompson, James F Glockner, Bernard F King, 2003, Kidney international.

Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype

Jeffrey M Slezak, E. Bergstralh, F. Stewart, 2003, The Lancet.

Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.

Bradley J Erickson, Panagiotis Korfiatis, Douglas Landsittel, 2017, Kidney international.

Segmentation of individual renal cysts from MR images in patients with autosomal dominant polycystic kidney disease.

Bumwoo Park, D. Landsittel, K. Bae, 2013, Clinical journal of the American Society of Nephrology : CJASN.

A complete mutation screen of PKHD1 in autosomal-recessive polycystic kidney disease (ARPKD) pedigrees.

Roser Torra, E. Coto, V. Torres, 2003, Kidney international.